Veritas Securities have done a research note, recommending a BUY, with a 12 month price range of $0.02 to $0.05.
Investment Case . CGP has late stage therapeutic delivery technologies in high value markets and indications. . Each investment has distinct advantages, with clear paths to commercialisation. . CGP operates a low fixed overhead model, giving substantial leverage to success on commercialisation of its investments. . CGP has a well-credentialed management team backed by successful best in field regulatory, intellectual property and scientific advisors.
CGP Price at posting:
12.5¢ Sentiment: Buy Disclosure: Held